Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
Clinical trial NCT02864849 · COMPLETED
Trial details
- NCT number
- NCT02864849
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-06-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.